HR Execs on the Move

Intersect ENT

www.intersectent.com

 
Intersect ENT (Nasdaq:XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Rahul Bitla
Director, Research and Development (R&D) Profile
Mark Alley
Vice President of Sales Profile
Reyna Fernandez
Chief Human Resource Officer Profile
Reyna Fernandez
Chief Human Resources Officer Profile
Gwen Carscadden
Chief People Officer Profile

Similar Companies

Carlisle Medical

Carlisle Medical is a Mobile, AL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Kern Surgical Supply

Kern Surgical Supply is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mobile Aspects

Mobile Aspects is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Health Products Inc

Global Health Products Inc is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Analogic

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.